InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Freedberg Jared, Directeur Juridique. Insider active across 1 company, notably Intercept Pharmaceuticals, INC.. Cumulatively, 12 disclosures have been logged. History available since 27 January 2022. The latest transaction was filed on 8 November 2023 (U). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Freedberg Jared
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
22,681 shares@ US$19.0065.4% of flowCommon StockSEC:0001104659-23-117099:0
771 shares@ US$18.962.2% of flowCommon StockSEC:0001104659-23-114267:0
771 shares@ US$10.501.2% of flowCommon StockSEC:0001104659-23-087247:0
771 shares@ US$17.071.9% of flowCommon StockSEC:0001104659-23-055476:0
918 shares@ US$18.762.6% of flowCommon StockSEC:0001104659-23-010467:0
12,200 shares0Common StockSEC:0001104659-23-008585:0
718 shares@ US$12.371.4% of flowCommon StockSEC:0001104659-23-000333:0
771 shares@ US$15.732.0% of flowCommon StockSEC:0001104659-22-114407:0
771 shares@ US$12.211.5% of flowCommon StockSEC:0001104659-22-085610:0
771 shares@ US$15.718.6% of flowCommon StockSEC:0001104659-22-055250:0
4,072 shares@ US$16.9145.7% of flowCommon StockSEC:0001104659-22-011363:0
10,300 shares0Common StockSEC:0001104659-22-009560:0
12 of 12 declarations
About Freedberg Jared
Jared Freedberg is the General Counsel at Intercept Pharmaceuticals, Inc. He oversees the company's legal matters, ensuring compliance and protection of the company's interests. His role is essential for risk management.
